Clinical Trial Program for Drugs for the Treatment of Herpes Labialis: An Analysis of FDA Guidance

N. N. Eremenko; Yu. V. Chernova; S. Yu. Serebrova

Safety and Risk of Pharmacotherapy
Bezopasnostʹ i risk farmakoterapii

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

User

eng | рус

Safety and Risk of Pharmacotherapy

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Eremenko N.N., Chernova Yu.V., Serebrova S.Yu. Clinical Trial Program for Drugs for the Treatment of Herpes Labialis: An Analysis of FDA Guidance. Safety and Risk of Pharmacotherapy. 2026;14(2):216-224. (In Russ.) https://doi.org/10.30895/2312-7821-2026-14-2-216-224

Views PDF (Rus): 8

JATS XML

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Safety and Risk of Pharmacotherapy

For citations:

Cookies policy